semaglutide advisory committee Getting to the heart of GLP-1 An FDA advisory committee voted

Wang, L., Wang, Q., Li, L., Kaelber, D

A large cardiovascular outcomes trial found that higher proportions of tirzepatide recipients reported vomiting, diarrhea, and nausea compared to those taking a selective GLP-1RA

GoodRx on Monday said it will also launch a weight-loss telehealth service for Wegovy and Ozempic at $39 a month for subscribers who sign up before February 1, 2026, rising to $119 a month afterward

It is particularly useful for patients with conditions that prevent the use of aspirin or ibuprofen

Divide your supply between two separate bags if possible

You Are Still in the Dose Adjustment Phase Many patients begin at a low dose that is not intended to fully suppress appetite